nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—FKBP1A—midbrain—Gilles de la Tourette syndrome	0.16	0.16	CbGeAlD
Everolimus—MTOR—nervous system—Gilles de la Tourette syndrome	0.146	0.146	CbGeAlD
Everolimus—MTOR—central nervous system—Gilles de la Tourette syndrome	0.141	0.141	CbGeAlD
Everolimus—FKBP1A—nervous system—Gilles de la Tourette syndrome	0.131	0.131	CbGeAlD
Everolimus—FKBP1A—central nervous system—Gilles de la Tourette syndrome	0.126	0.126	CbGeAlD
Everolimus—MTOR—brain—Gilles de la Tourette syndrome	0.112	0.112	CbGeAlD
Everolimus—FKBP1A—brain—Gilles de la Tourette syndrome	0.1	0.1	CbGeAlD
Everolimus—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.0429	0.0429	CbGeAlD
Everolimus—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.0413	0.0413	CbGeAlD
